Valuation Update With 7 Day Price Move • Jul 17
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥24.39, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 12% over the past three years. Annonce • Jun 30
Weihai Guangwei Composites Co., Ltd. to Report First Half, 2026 Results on Aug 25, 2026 Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2026 results on Aug 25, 2026 Annonce • Apr 24
Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 20, 2026 Weihai Guangwei Composites Co., Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Weihai, Shandong China Annonce • Mar 31
Weihai Guangwei Composites Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 Annonce • Dec 31
Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 Annonce • Sep 30
Weihai Guangwei Composites Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Weihai Guangwei Composites Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Annonce • Jul 02
Weihai Guangwei Composites Co., Ltd. to Report First Half, 2025 Results on Aug 19, 2025 Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2025 results on Aug 19, 2025 Annonce • Apr 23
Weihai Guangwei Composites Co., Ltd. Approves Cash Dividend for 2024 Weihai Guangwei Composites Co., Ltd. at its Annual General Meeting held on 21 April 2025 approved cash dividend of CNY 5.00000000 per 10 shares (tax included) for 2024. Annonce • Apr 02
Weihai Guangwei Composites Co., Ltd. Announces Profit Distribution Proposal for the Year 2024 Weihai Guangwei Composites Co., Ltd. announced profit distribution proposal final Cash dividend/10 shares (tax included) is CNY 5.00000 for the year 2024. Annonce • Apr 01
Weihai Guangwei Composites Co., Ltd., Annual General Meeting, Apr 21, 2025 Weihai Guangwei Composites Co., Ltd., Annual General Meeting, Apr 21, 2025, at 14:00 China Standard Time. Location: No. 130, Tianjin Road, Gaoqu, Weihai, Shandong China Annonce • Mar 31
Weihai Guangwei Composites Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Annonce • Dec 31
Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2024 Results on Apr 22, 2025 Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2024 results on Apr 22, 2025 Reported Earnings • Oct 28
Third quarter 2024 earnings released: EPS: CN¥0.30 (vs CN¥0.25 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.30 (up from CN¥0.25 in 3Q 2023). Revenue: CN¥746.3m (up 43% from 3Q 2023). Net income: CN¥246.7m (up 19% from 3Q 2023). Profit margin: 33% (down from 40% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to CN¥32.92, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 16% over the past three years. Annonce • Sep 30
Weihai Guangwei Composites Co., Ltd. to Report Q3, 2024 Results on Oct 28, 2024 Weihai Guangwei Composites Co., Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024 Reported Earnings • Aug 27
Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.29 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.26 (down from CN¥0.29 in 2Q 2023). Revenue: CN¥644.5m (down 3.4% from 2Q 2023). Net income: CN¥211.0m (down 13% from 2Q 2023). Profit margin: 33% (down from 36% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Annonce • Jun 29
Weihai Guangwei Composites Co., Ltd. to Report First Half, 2024 Results on Aug 27, 2024 Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2024 results on Aug 27, 2024 Annonce • Jun 26
Weihai Guangwei Composites Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 03 July 2024 Weihai Guangwei Composites Co., Ltd. announced final cash dividend of CNY 5.00 per 10 shares on A shares (tax included) for the year 2023. Record date: 02 July 2024, Ex-date: 03 July 2024 and Payment date: 03 July 2024. Reported Earnings • Apr 29
First quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.21 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.19 (down from CN¥0.21 in 1Q 2023). Revenue: CN¥511.6m (down 8.1% from 1Q 2023). Net income: CN¥157.3m (down 8.2% from 1Q 2023). Profit margin: 31% (in line with 1Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 09
Full year 2023 earnings released: EPS: CN¥1.05 (vs CN¥1.13 in FY 2022) Full year 2023 results: EPS: CN¥1.05 (down from CN¥1.13 in FY 2022). Revenue: CN¥2.52b (flat on FY 2022). Net income: CN¥873.2m (down 6.5% from FY 2022). Profit margin: 35% (down from 37% in FY 2022). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Annonce • Mar 30
Weihai Guangwei Composites Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024 Weihai Guangwei Composites Co., Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024 Buy Or Sell Opportunity • Mar 22
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 18% to CN¥31.36. The fair value is estimated to be CN¥25.59, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 9.3%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 47% in the next 2 years. Valuation Update With 7 Day Price Move • Feb 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥27.24, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 50% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.67 per share. Reported Earnings • Jan 30
Full year 2023 earnings released: EPS: CN¥1.05 (vs CN¥1.13 in FY 2022) Full year 2023 results: EPS: CN¥1.05 (down from CN¥1.13 in FY 2022). Revenue: CN¥2.52b (flat on FY 2022). Net income: CN¥869.1m (down 7.0% from FY 2022). Profit margin: 35% (down from 37% in FY 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Annonce • Jan 01
Weihai Guangwei Composites Co., Ltd. (SZSE:300699) announces an Equity Buyback for CNY 300 million worth of its shares. Weihai Guangwei Composites Co., Ltd. (SZSE:300699) announces a share repurchase program. Under the program, the company will repurchase up to CNY 300 million worth of its Class A shares. The shares will be repurchased at no more than CNY 37.35 per share. The purpose of the program is to maintain company value and shareholder rights. The plan will be valid for 3 months. Annonce • Dec 30
Weihai Guangwei Composites Co., Ltd. to Report Fiscal Year 2023 Results on Apr 09, 2024 Weihai Guangwei Composites Co., Ltd. announced that they will report fiscal year 2023 results on Apr 09, 2024 Valuation Update With 7 Day Price Move • Dec 22
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥26.53, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥27.13 per share. Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.29 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.25 (down from CN¥0.29 in 3Q 2022). Revenue: CN¥523.2m (down 16% from 3Q 2022). Net income: CN¥208.0m (down 15% from 3Q 2022). Profit margin: 40% (in line with 3Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 15
Second quarter 2023 earnings released: EPS: CN¥0.29 (vs CN¥0.36 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.29 (down from CN¥0.36 in 2Q 2022). Revenue: CN¥666.9m (down 7.8% from 2Q 2022). Net income: CN¥241.8m (down 19% from 2Q 2022). Profit margin: 36% (down from 41% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings. Annonce • Jul 01
Weihai Guangwei Composites Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023 Weihai Guangwei Composites Co., Ltd. announced that they will report first half, 2023 results on Aug 15, 2023 Upcoming Dividend • May 04
Upcoming dividend of CN¥0.70 per share at 1.3% yield Eligible shareholders must have bought the stock before 11 May 2023. Payment date: 11 May 2023. Payout ratio is a comfortable 40% but the company is not cash flow positive. Trailing yield: 1.3%. Lower than top quartile of Chinese dividend payers (1.9%). Lower than average of industry peers (1.9%). Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥51.06, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.6% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥34.88 per share. Reported Earnings • Mar 29
Full year 2022 earnings released: EPS: CN¥1.80 (vs CN¥1.46 in FY 2021) Full year 2022 results: EPS: CN¥1.80 (up from CN¥1.46 in FY 2021). Revenue: CN¥2.51b (down 3.7% from FY 2021). Net income: CN¥934.3m (up 23% from FY 2021). Profit margin: 37% (up from 29% in FY 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jan 12
Full year 2022 earnings released: EPS: CN¥1.80 (vs CN¥1.46 in FY 2021) Full year 2022 results: EPS: CN¥1.80 (up from CN¥1.46 in FY 2021). Revenue: CN¥2.52b (down 3.4% from FY 2021). Net income: CN¥931.9m (up 23% from FY 2021). Profit margin: 37% (up from 29% in FY 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.35 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.47 (up from CN¥0.35 in 3Q 2021). Revenue: CN¥625.8m (down 7.9% from 3Q 2021). Net income: CN¥244.7m (up 33% from 3Q 2021). Profit margin: 39% (up from 27% in 3Q 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Aug 17
Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.42 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.57 (up from CN¥0.42 in 2Q 2021). Revenue: CN¥723.6m (up 9.9% from 2Q 2021). Net income: CN¥298.1m (up 38% from 2Q 2021). Profit margin: 41% (up from 33% in 2Q 2021). The increase in margin was primarily driven by higher revenue. Over the next year, revenue is forecast to grow 36%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 18
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥68.39, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 92% over the past three years. Valuation Update With 7 Day Price Move • May 02
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥49.81, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥22.42 per share. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.42 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.40 (down from CN¥0.42 in 1Q 2021). Revenue: CN¥590.9m (down 5.5% from 1Q 2021). Net income: CN¥207.5m (down 5.0% from 1Q 2021). Profit margin: 35% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 36%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Independent Director Wenguang Tian is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Apr 14
Full year 2021 earnings released: EPS: CN¥1.46 (vs CN¥1.24 in FY 2020) Full year 2021 results: EPS: CN¥1.46 (up from CN¥1.24 in FY 2020). Revenue: CN¥2.61b (up 23% from FY 2020). Net income: CN¥758.4m (up 18% from FY 2020). Profit margin: 29% (down from 30% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 29%, compared to a 53% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 26
Third quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.33 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥679.3m (up 14% from 3Q 2020). Net income: CN¥184.2m (up 6.7% from 3Q 2020). Profit margin: 27% (down from 29% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Aug 24
Second quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.35 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥658.4m (up 27% from 2Q 2020). Net income: CN¥215.6m (up 20% from 2Q 2020). Profit margin: 33% (down from 35% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 04
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥79.91, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 176% over the past three years. Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.33 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥625.0m (up 28% from 1Q 2020). Net income: CN¥218.5m (up 27% from 1Q 2020). Profit margin: 35% (in line with 1Q 2020). Reported Earnings • Mar 30
Full year 2020 earnings released: EPS CN¥1.24 (vs CN¥1.01 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥2.12b (up 23% from FY 2019). Net income: CN¥641.7m (up 23% from FY 2019). Profit margin: 30% (in line with FY 2019). Is New 90 Day High Low • Mar 01
New 90-day low: CN¥72.78 The company is down 2.0% from its price of CN¥74.54 on 01 December 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥12.20 per share. Valuation Update With 7 Day Price Move • Feb 23
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥74.59, the stock is trading at a trailing P/E ratio of 60.2x, down from the previous P/E ratio of 73x. This compares to an average P/E of 37x in the Chemicals industry in China. Total returns to shareholders over the past year are 33%. Reported Earnings • Feb 02
Full year 2020 earnings released: EPS CN¥1.24 (vs CN¥1.01 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥2.12b (up 23% from FY 2019). Net income: CN¥641.6m (up 23% from FY 2019). Profit margin: 30% (in line with FY 2019). Analyst Estimate Surprise Post Earnings • Feb 02
Revenue beats expectations Revenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 24%, compared to a 51% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Dec 25
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥89.09, the stock is trading at a trailing P/E ratio of 76.8x, up from the previous P/E ratio of 66.7x. This compares to an average P/E of 34x in the Chemicals industry in China. Total returns to shareholders over the past year are 97%. Is New 90 Day High Low • Dec 21
New 90-day high: CN¥82.30 The company is up 15% from its price of CN¥71.70 on 23 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥8.63 per share. Is New 90 Day High Low • Oct 30
New 90-day low: CN¥66.07 The company is down 15% from its price of CN¥77.55 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥9.38 per share. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥602.0m, up 18% from the prior year. Total revenue was CN¥2.01b over the last 12 months, up 19% from the prior year. Analyst Estimate Surprise Post Earnings • Oct 28
Third-quarter earnings released: Revenue beats expectations Third-quarter revenue exceeded analyst estimates by 2.9% at CN¥598.4m. Revenue is forecast to grow 24% over the next year, compared to a 44% growth forecast for the Chemicals industry in China. 
